Gerald R. Ewoldt

Array ( [id] => 6062204 [patent_doc_number] => 20110200610 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'Immuno-Modulating Compositions for the Treatment of Immune-Mediated Disorders' [patent_app_type] => utility [patent_app_number] => 12/879129 [patent_app_country] => US [patent_app_date] => 2010-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 81 [patent_figures_cnt] => 81 [patent_no_of_words] => 75181 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20110200610.pdf [firstpage_image] =>[orig_patent_app_number] => 12879129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8300963 [patent_doc_number] => 20120183518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'ASSAY FOR DETERMINING HEALTH OF CD8+ T CELLS' [patent_app_type] => utility [patent_app_number] => 13/392481 [patent_app_country] => US [patent_app_date] => 2010-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16022 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13392481 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8346844 [patent_doc_number] => 20120207773 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-16 [patent_title] => 'MATERIALS AND METHODS FOR THE DEVELOPMENT OF AN ANTIGEN-SPECIFIC IMMUNE NON-RESPONSIVENESS STATE' [patent_app_type] => utility [patent_app_number] => 13/391127 [patent_app_country] => US [patent_app_date] => 2010-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3360 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13391127 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6392166 [patent_doc_number] => 20100303833 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'Method for Identifying a MHC Class H-Dependent Tumor Associated T Helper Cell Antigen' [patent_app_type] => utility [patent_app_number] => 12/857960 [patent_app_country] => US [patent_app_date] => 2010-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13195 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0303/20100303833.pdf [firstpage_image] =>[orig_patent_app_number] => 12857960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6134984 [patent_doc_number] => 20110008799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'PHENOTYPIC RATIO OF SERUM AMYLOID IN PRE- AND TYPE 2 DIABETES' [patent_app_type] => utility [patent_app_number] => 12/829906 [patent_app_country] => US [patent_app_date] => 2010-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3810 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008799.pdf [firstpage_image] =>[orig_patent_app_number] => 12829906 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8199854 [patent_doc_number] => 20120123099 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'AUTOANTIBODY PRODUCTION INHIBITOR' [patent_app_type] => utility [patent_app_number] => 13/387081 [patent_app_country] => US [patent_app_date] => 2010-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5602 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20120123099.pdf [firstpage_image] =>[orig_patent_app_number] => 13387081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10517016 [patent_doc_number] => 09244059 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-01-26 [patent_title] => 'Cytotoxic anti-LAG-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune disease' [patent_app_type] => utility [patent_app_number] => 12/823795 [patent_app_country] => US [patent_app_date] => 2010-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 23 [patent_no_of_words] => 11921 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12823795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6510234 [patent_doc_number] => 20100261190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'Mammalian Genes; Related Reagents and Methods' [patent_app_type] => utility [patent_app_number] => 12/819055 [patent_app_country] => US [patent_app_date] => 2010-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25318 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20100261190.pdf [firstpage_image] =>[orig_patent_app_number] => 12819055 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9354769 [patent_doc_number] => 08673300 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-18 [patent_title] => 'Therapeutic compositions and methods for the prevention of autoimmune diseases' [patent_app_type] => utility [patent_app_number] => 13/376122 [patent_app_country] => US [patent_app_date] => 2010-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 14426 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13376122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6392199 [patent_doc_number] => 20100303835 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'PEPTOID LIGANDS FOR ISOLATION AND TREATMENT OF AUTOIMMUNE T-CELLS' [patent_app_type] => utility [patent_app_number] => 12/789711 [patent_app_country] => US [patent_app_date] => 2010-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 27411 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0303/20100303835.pdf [firstpage_image] =>[orig_patent_app_number] => 12789711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6582019 [patent_doc_number] => 20100291123 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'T Cell Receptor CDR3 Sequences and Methods for Detection' [patent_app_type] => utility [patent_app_number] => 12/777487 [patent_app_country] => US [patent_app_date] => 2010-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10622 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291123.pdf [firstpage_image] =>[orig_patent_app_number] => 12777487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8943762 [patent_doc_number] => 08496938 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-30 [patent_title] => 'Anti-CD100 neutralizing neutralizing antibodies and methods of using the same' [patent_app_type] => utility [patent_app_number] => 12/776187 [patent_app_country] => US [patent_app_date] => 2010-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 32 [patent_no_of_words] => 38436 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12776187 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6540389 [patent_doc_number] => 20100287637 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'METHODS OF BLOCKING TISSUE DESTRUCTION BY AUTOREACTIVE T CELLS' [patent_app_type] => utility [patent_app_number] => 12/774926 [patent_app_country] => US [patent_app_date] => 2010-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 12087 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20100287637.pdf [firstpage_image] =>[orig_patent_app_number] => 12774926 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6433823 [patent_doc_number] => 20100278823 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'TREATMENT OF TYPE 1 DIABETES BEFORE AND AFTER EXPRESSION OF PREDISPOSITION MARKERS' [patent_app_type] => utility [patent_app_number] => 12/773401 [patent_app_country] => US [patent_app_date] => 2010-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 20201 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0278/20100278823.pdf [firstpage_image] =>[orig_patent_app_number] => 12773401 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6568791 [patent_doc_number] => 20100273204 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'METHODS FOR MONITORING THE EFFICACY OF ANTI-IL-2R ANTIBODIES IN MULTIPLE SCLEROSIS PATIENTS' [patent_app_type] => utility [patent_app_number] => 12/768131 [patent_app_country] => US [patent_app_date] => 2010-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8778 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0273/20100273204.pdf [firstpage_image] =>[orig_patent_app_number] => 12768131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6504042 [patent_doc_number] => 20100260755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'IBUDILAST AND IMMUNOMODULATORS COMBINATION' [patent_app_type] => utility [patent_app_number] => 12/755939 [patent_app_country] => US [patent_app_date] => 2010-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7056 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20100260755.pdf [firstpage_image] =>[orig_patent_app_number] => 12755939 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6235338 [patent_doc_number] => 20100267042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'Antigen-Presenting Cell Populations And Their Use As Reagents For Enhancing Or Reducing Immune Tolerance' [patent_app_type] => utility [patent_app_number] => 12/798307 [patent_app_country] => US [patent_app_date] => 2010-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 23388 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20100267042.pdf [firstpage_image] =>[orig_patent_app_number] => 12798307 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8054189 [patent_doc_number] => 20120076831 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'COMPOSITIONS AND METHODS FOR INDUCTION OF ANTIGEN-SPECIFIC TOLERANCE' [patent_app_type] => utility [patent_app_number] => 13/144918 [patent_app_country] => US [patent_app_date] => 2010-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 24110 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20120076831.pdf [firstpage_image] =>[orig_patent_app_number] => 13144918 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6228808 [patent_doc_number] => 20100183546 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'Method for Increasing CD8+ Cytotoxic T Cell Responses and for Treating Multiple Sclerosis' [patent_app_type] => utility [patent_app_number] => 12/630228 [patent_app_country] => US [patent_app_date] => 2009-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 6400 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183546.pdf [firstpage_image] =>[orig_patent_app_number] => 12630228 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6582722 [patent_doc_number] => 20100129934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'Glycated Insulin as a Biomarker for Diagnosis and Monitoring of Diabetes' [patent_app_type] => utility [patent_app_number] => 12/620973 [patent_app_country] => US [patent_app_date] => 2009-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3605 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20100129934.pdf [firstpage_image] =>[orig_patent_app_number] => 12620973 [rel_patent_id] =>[rel_patent_doc_number] =>)